Outcomes 2 Years After Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk

Dr. Madeleine Barker presented the Two Years Outcomes of PARTNER 3, which is a randomized controlled clinical trial looking at transcatheter valve replacement (TAVR) in patients with symptomatic severe aortic stenosis and low surgical risk as compared to surgical aortic valve replacement (SAVR). This trial was published last month in JACC.